Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1663-1672
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1663
Table 1 Demographics and preoperative characteristics of patients with adenocarcinoma of the pancreas undergoing a pancreaticoduodenectomy from 2015 to 2019, n (%)
CharacteristicSubcategoryInitial surgery
Neoadjuvant radiation
P value
n = 9988
n = 1470
Age in yrLess than 50511 (5.1)89 (6.1)
50-591638 (16.4)304 (20.7)
60-693526 (35.3)585 (39.8)< 0.001a
70-793287 (32.9)430 (29.3)
80 and above1026 (10.3)62 (4.2)
Male5340 (53.5)743 (50.5)0.036a
RaceWhite7392 (81.6)1203 (84.3)
Black/African American748 (8.3)127 (8.9)
Hispanic462 (5.1)54 (3.8)< 0.001a
Asian427 (4.7)38 (2.7)
Other33 (0.4)5 (0.4)
Not reported92643
BMINormal3683 (36.9)618 (42.0)
Underweight244 (2.4)37 (2.5)
Overweight3591 (36)505 (34.4)0.002a
Obese1614 (16.2)203 (13.8)
Morbidly obese856 (8.6)107 (7.3)
Diabetes2859 (28.6)461 (31.4)0.031a
Smoking1650 (16.5)238 (16.2)0.751
COPD394 (3.9)42 (2.9)0.042a
Dyspnea507 (5.1)57 (3.9)0.047a
HTN5418 (54.2)693 (47.1)< 0.001a
Preoperative steroid use239 (2.4)42 (2.9)0.283
Jaundice5759 (58.0)431 (29.7)< 0.001a
Biliary stent6457 (64.7)979 (66.6)0.235
Albumin, mean ± SD3.69 (0.60)3.85 (0.50)< 0.001a